2013 annual hematology meeting: cll - upfront therapy
Published 10 years ago • 275 plays • Length 16:18Download video MP4
Download video MP3
Similar videos
-
21:42
2013 annual hematology meeting: multiple myeloma - upfront therapy
-
5:23
2013 annual hematology meeting: acute leukemia - all & cart therapy
-
25:33
2013 annual hematology meeting: cml - clinical trial updates
-
10:47
2013 annual hematology meeting: cll - novel agents
-
15:28
2013 annual hematology meeting: cll - relapsed disease
-
11:43
2013 annual hematology meeting: lymphoma - ibrutinib & idelalisib
-
19:55
2013 annual hematology meeting: multiple myeloma - novel agents
-
16:04
2013 annual hematology meeting: multiple myeloma - maintenance and relapse
-
11:48
2013 annual hematology meeting: lymphoma - lenalidomide
-
9:52
2013 annual hematology meeting: lymphoma - rituximab maintenance therapy
-
19:41
2014 annual hematology meeting: cml
-
20:17
2014 annual hematology meeting: cll
-
27:41
novel insights into cll b cells and their environment: opportunities for therapy
-
23:18
international myeloma workshop 2013: frontline therapy
-
17:36
best of the day: from the 2016 annual hematology meeting - cll
-
24:30
management of thrombosis risk with ponatinib and other tkis for cml?
-
0:34
professor peter hillmen - treating patients with chronic lymphocytic leukaemia (cll)
-
21:19
other new molecules in the cll pipeline: pi3k inhibitors, syk inhibitors, etc.